Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Using Mobile Phone Short Message Service (SMS) Reminders to Enhance Type 2 Diabetes Mellitus Appointment Attendance in a Primary Care Clinic
A randomized controlled trial of patients with type 2 diabetes mellitus with multiple appointments into short message service group and control group. The attendance rate of these two groups of patients will be compared.
The main objective of this study is to evaluate the appointment attendance rate using SMS
reminder of nurses and allied health appointments for diabetic patients, when compared to
conventional telephone reminder and no reminder. We also aim at determine the factors
associated with appointment attendance. Finally, we will also survey patients' acceptance
and satisfaction to the SMS service.
This is a single blind randomization study. It will be carried out in Ha Kwai Chung General
Outpatient Clinic.
The primary outcome of this study is to evaluate the attendance rate of each individual
doctor, nurses and allied health clinic appointments for diabetic patients, as well as their
overall attendance rates:
1. Diabetes Complication Screening Clinic (OPAS DMCS/RDNA)
2. Diabetes Nurse Intervention Clinic (OPAS DMIC/RDNI)
3. DM nurse group (OPAS RDNG)
4. Dietitian Counselling (OPAS DC/DG)
5. Physiotherapy (OPAS PTC/PTG)
6. Diabetes Doctor Session (OPAS RDR)
7. Retino photo Assessment (OPAS RDO)
8. Blood taking appointment (OPAS LABT)
The secondary outcomes are:
- Acceptance Rate of SMS Reminder Vs Telephone Reminder Vs no reminder
- Factors associated with acceptance of SMS
1. Personal Parameters: Age, sex, educational level, occupation, mobile phone models,
Habit of using mobile phone service
2. Disease Parameters: Number and types of comorbidity, disease control (by
biochemical markers)
3. Quality of Life (by SF-6D)
- Reported adverse effects of the reminder system
- Chang in biochemical markers (BMI, HbA1c, LDL-c level) 6-9 months later
Subjects who agreed to participate in this study will first receive a survey on the
acceptance of SMS service. For those agree to receive SMS reminder, they will be randomized
to:
1. an SMS remind them to come for scheduled clinic appointment 24-72 hours before, or
2. usual care with no reminder / telephone reminder.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |